# FDA Inspection 1201162 - Beximco Pharmaceuticals Limited - March 30, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/beximco-pharmaceuticals-limited/fca6aa82-6dd0-4a6c-aa6d-d2449b480320/
Source feed: FDA_Inspections

> FDA Inspection 1201162 for Beximco Pharmaceuticals Limited on March 30, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201162
- Company Name: Beximco Pharmaceuticals Limited
- Inspection Date: 2023-03-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 914961 - 2015-01-22](https://www.globalkeysolutions.net/api/records/fda_inspections/beximco-pharmaceuticals-limited/fc6b8f29-8e86-43b6-b904-260e3461c8a6/)

Company: https://www.globalkeysolutions.net/companies/beximco-pharmaceuticals-limited/1e6f8a78-2764-4bc4-b91e-0b37ae1ac008

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c